<?xml version="1.0" encoding="UTF-8"?>
<results title="test_trace">
 <result pre="Health Organization on March 11, 2020. Drugs are the main" exact="treatment" post="of COVID-19 patients. Pharmaceutical service offers drug safety ensurance"/>
 <result pre="prevention and control policy and requirements, combined with series of" exact="diagnosis" post="and treatment plans, pharmacists in the first provincial-level COVID-19"/>
 <result pre="control policy and requirements, combined with series of diagnosis and" exact="treatment" post="plans, pharmacists in the first provincial-level COVID-19 diagnosis and"/>
 <result pre="diagnosis and treatment plans, pharmacists in the first provincial-level COVID-19" exact="diagnosis" post="and treatment unit in Jilin Province in Northeast China"/>
 <result pre="treatment plans, pharmacists in the first provincial-level COVID-19 diagnosis and" exact="treatment" post="unit in Jilin Province in Northeast China have established"/>
 <result pre="boosted the pharmacists' confidence in fighting the epidemic. For the" exact="treatment" post="of COVID-19, pharmacists conducted adverse reaction monitoring and participated"/>
 <result pre="patients. The hospital was specified as the first provincial-level COVID-19" exact="diagnosis" post="and treatment unit in Jilin Province.3 During COVID-19 outbreak-period,"/>
 <result pre="hospital was specified as the first provincial-level COVID-19 diagnosis and" exact="treatment" post="unit in Jilin Province.3 During COVID-19 outbreak-period, the pressure"/>
 <result pre="of pharmaceuticals, and guide suspected cases to fever clinic for" exact="screening" post="as required. The second team members received epidemic prevention"/>
 <result pre="mainly online learning, the contents included three aspects: a. Hospital" exact="isolation" post="rules training, including: transfer routes, transfer vehicles and dedicated"/>
 <result pre="designated routes, which help to reduce the risk of nosocomial" exact="infection" post="and ensure the supply of drugs.8 b. Prevention training."/>
 <result pre="how to protect themselves from getting infected. A Systematic nosocomial" exact="infection" post="prevention and control training have been provided for pharmacists,"/>
 <result pre="use and destruct hats, masks, protective clothing correctly. c. COVID-19" exact="diagnosis" post="and treatment plans training. From January to now, the"/>
 <result pre="destruct hats, masks, protective clothing correctly. c. COVID-19 diagnosis and" exact="treatment" post="plans training. From January to now, the COVID-19 diagnosis"/>
 <result pre="and treatment plans training. From January to now, the COVID-19" exact="diagnosis" post="and treatment plans have been updated seven times and"/>
 <result pre="plans training. From January to now, the COVID-19 diagnosis and" exact="treatment" post="plans have been updated seven times and several diagnosis"/>
 <result pre="and treatment plans have been updated seven times and several" exact="diagnosis" post="and treatment plans webinars have been organized. Through the"/>
 <result pre="plans have been updated seven times and several diagnosis and" exact="treatment" post="plans webinars have been organized. Through the training, pharmacists"/>
 <result pre="have been organized. Through the training, pharmacists can master the" exact="isolation" post="system, personal safety protection operation and latest treatment plans."/>
 <result pre="master the isolation system, personal safety protection operation and latest" exact="treatment" post="plans. Scientific human resource mechanisms, adequate personal protection and"/>
 <result pre="have carried out four practices:(1)establishing drug supply schemes based on" exact="treatment" post="guidelines, (2)Implementing online drug procurement,(3)managing donated medicine,(4)managing environment. (1)Pharmacists"/>
 <result pre="establish COVID-19 prevention and control drug supply schemes based on" exact="diagnosis" post="and treatment plans, and the drugs on the list"/>
 <result pre="prevention and control drug supply schemes based on diagnosis and" exact="treatment" post="plans, and the drugs on the list have been"/>
 <result pre="procured at first time. Table 1 List of THJU COVID-19" exact="treatment" post="drugs.9, 10, 11 Table 1 Type of treatment Drug"/>
 <result pre="THJU COVID-19 treatment drugs.9, 10, 11 Table 1 Type of" exact="treatment" post="Drug name Antiviral drugs Interferon α - 2b injection,"/>
 <result pre="and material resources, and reduced infectious risk caused by cross" exact="contact" post="in the drug purchase process as much as possible."/>
 <result pre="environment is an important condition to ensure the progress of" exact="diagnosis" post="and treatment. In order to reduce the spread of"/>
 <result pre="drug delays. Up to now, there has been no nosocomial" exact="infection" post="related to pharmacy. 4 Practice 3: management of off-label"/>
 <result pre="with COVID-19 could be defined as off-label drug use, the" exact="treatment" post="is lack of clinical experience. The incidence of severe"/>
 <result pre="serious ADR occurred. In addition, pharmacists participated in the multidisciplinary" exact="diagnosis" post="and treatment of COVID-19 patients, conducted nutritional risk screening"/>
 <result pre="occurred. In addition, pharmacists participated in the multidisciplinary diagnosis and" exact="treatment" post="of COVID-19 patients, conducted nutritional risk screening and designed"/>
 <result pre="multidisciplinary diagnosis and treatment of COVID-19 patients, conducted nutritional risk" exact="screening" post="and designed nutritional support programs. During the outbreak, all"/>
 <result pre="Practice 4: pharmaceutical care Timely pharmaceutical care are critical for" exact="treatment" post="during the coronavirus pandemic. Pharmacists have made a pharmaceutical"/>
 <result pre="(Fig. 3 )according to needs of different groups, provided updated" exact="treatment" post="plans, monitored potential drug interactions, focus on special population"/>
 <result pre="To have a better grasp on the latest version of" exact="diagnosis" post="and treatment plans for frontline physicians, pharmacists made a"/>
 <result pre="a better grasp on the latest version of diagnosis and" exact="treatment" post="plans for frontline physicians, pharmacists made a list of"/>
 <result pre="of changes(Table 3 ). Table 3 List of changes in" exact="diagnosis" post="and treatment plans for COVID-19.15,16 Table 3 Diagnosis and"/>
 <result pre="3 ). Table 3 List of changes in diagnosis and" exact="treatment" post="plans for COVID-19.15,16 Table 3 Diagnosis and treatment of"/>
 <result pre="diagnosis and treatment plans for COVID-19.15,16 Table 3 Diagnosis and" exact="treatment" post="of COVID-19 Antiviral therapy Antimicrobial treatment Hormone therapy Immunotherapy"/>
 <result pre="Table 3 Diagnosis and treatment of COVID-19 Antiviral therapy Antimicrobial" exact="treatment" post="Hormone therapy Immunotherapy First edition There is currently no"/>
 <result pre="of endemic epidemiology or other infection-related risk factors, empirical therapeutic" exact="treatment" post="can be provided, including Oseltamivir or Abidor. Avoid blind"/>
 <result pre="need to be paid attention, meanwhile tuberculosis and other active" exact="infection" post="is contraindicated. Pharmacists also provided a list of common"/>
 <result pre="warnings of potential drug interactions and reactions according to COVID-19" exact="diagnosis" post="and treatment plans combined with literatures (Table 4). Pregnant"/>
 <result pre="potential drug interactions and reactions according to COVID-19 diagnosis and" exact="treatment" post="plans combined with literatures (Table 4). Pregnant women, especially"/>
 <result pre="COVID-19.18 Gestational age, and whether to terminate the pregnancy after" exact="treatment" post="has been considered in the therapy.16 Older adults are"/>
 <result pre="April 2020http://www.nhc.gov.cn/xcs/zhengcwj/202001/44a3b8245e8049d2837a4f27529cd386.shtml 3Health commission of Jilin ProvinceList of designated medical" exact="treatment" post="institutions of covid-19 in Jilin Province.20202020http://wsjkw.jl.gov.cn/zwgk/gsgg/202001/t20200121_6549038.htmlAccessed date: 1 April"/>
 <result pre="commission of Jilin ProvinceList of designated medical treatment institutions of" exact="covid-19" post="in Jilin Province.20202020http://wsjkw.jl.gov.cn/zwgk/gsgg/202001/t20200121_6549038.htmlAccessed date: 1 April 2020 4International Pharmaceutical"/>
 <result pre="Commission of the People’s Republic of ChinaNotice on novel coronavirus" exact="infection" post="prevention and control technical guidelines (First Edition) in medical"/>
 <result pre="11National Health Commission of the People’s Republic of ChinaDiagnosis and" exact="treatment" post="of COVID-19(version 5)20202020http://www.nhc.gov.cn/xcs/zhengcwj/202002/3b09b894ac9b4204a79db5b8912d4440.shtmlAccessed date: 1 April 2020 12Standing Committee"/>
 <result pre="16National Health Commission of the People’s Republic of ChinaDiagnosis and" exact="treatment" post="of COVID-19(version 7)2020Accessed date: 1 April 2020http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml 17ZhaoR.S.YangY.H.YangL.Novel coronavirus"/>
 <result pre="prevention strategy: pharmaceutical guidance and management strategyChin Pharmaceut J2020http://kns.cnki.net/kcms/detail/11.2162.R.20200207.0936.002.html 18ZhuY.G.DengZ.W.LiuL.H.COVID-19" exact="treatment" post="protocol (drug information) compilation (First Edition), Cntrl S Pharmhttp://kns.cnki.net/kcms/detail/43.1408.R.20200221.0859.002.html"/>
 <result pre="information) compilation (First Edition), Cntrl S Pharmhttp://kns.cnki.net/kcms/detail/43.1408.R.20200221.0859.002.html 19ZhaoD.C.JinR.M.LiuZ.S.Recommendation for the" exact="diagnosis" post="and treatment of novel coronavirus infection in children in"/>
 <result pre="(First Edition), Cntrl S Pharmhttp://kns.cnki.net/kcms/detail/43.1408.R.20200221.0859.002.html 19ZhaoD.C.JinR.M.LiuZ.S.Recommendation for the diagnosis and" exact="treatment" post="of novel coronavirus infection in children in Hubei (Trial"/>
 <result pre="Pharmhttp://kns.cnki.net/kcms/detail/43.1408.R.20200221.0859.002.html 19ZhaoD.C.JinR.M.LiuZ.S.Recommendation for the diagnosis and treatment of novel coronavirus" exact="infection" post="in children in Hubei (Trial version 1)Chin J Contemp"/>
</results>
